Prometheus Therapeutics Inc.

MIRAMAR, FL · CIK 0001823161 · Medtech · Acquired

Photobiomodulation (PBM) therapy system for accelerated healing of cerebral aneurysms

prometheustherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.8M
4 Form D · Nov 2025
11 months since last filing
Contracts
—
No federal contracts on record
Patents
6
2 granted · 4 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$287,107
Private capital raisedForm D · SEC$345,000
Private capital raisedForm D · SEC$1,052,665
Private capital raisedForm D · SEC$130,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1109EPIEN MEDICAL, INC.—$900K
1110OnPoint Surgical, Inc.—$200K
1111Renovo Concepts, Inc.—$3.3M
1112Prometheus Therapeutics Inc.—$1.8M
1113NOVOCUFF INC—$6.8M
1114MOBILE SENSE TECHNOLOGIES, INC.—$500K
1115Mate Fertility, Inc.—$5.7M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • Alexander HastingsDirector
  • Baruch LieberDirector · Executive Officer
  • Marc LitzenbergDirector · Executive Officer
  • John McEleneyDirector
  • Bernardo NavarroExecutive Officer
  • Bernie NavarroExecutive Officer
  • Ajay WakhlooDirector · Executive Officer

Patents

USPTO · 2 granted of 6

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.